Sulpiride‐induced tardive dystonia
Identifieur interne : 006272 ( Main/Exploration ); précédent : 006271; suivant : 006273Sulpiride‐induced tardive dystonia
Auteurs : Lucinda G. Miller [États-Unis] ; Jankovic [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 1990.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Adult, Antidepressant agent, Antipsychotic Agents (adverse effects), Antipsychotic Agents (therapeutic use), Case study, D2 Dopamine receptor, Dopamine antagonist, Dyskinesia, Drug-Induced (etiology), Dystonia, Dystonia (chemically induced), Human, Humans, Late, Male, Nervous system diseases, Parkinsonism, Psychotic Disorders (drug therapy), Psychotropic, Receptors, Dopamine (drug effects), Receptors, Dopamine D2, Sulpiride, Sulpiride (adverse effects), Sulpiride (therapeutic use), Tardive dystonia, Toxicity.
- MESH :
- chemical , adverse effects : Antipsychotic Agents, Sulpiride.
- chemical , drug effects : Receptors, Dopamine.
- chemical , therapeutic use : Antipsychotic Agents, Sulpiride.
- chemically induced : Dystonia.
- drug therapy : Psychotic Disorders.
- etiology : Dyskinesia, Drug-Induced.
- Adult, Humans, Male, Receptors, Dopamine D2.
Abstract
Sulpiride is a selective D2‐receptor antagonist with antipsychotic and antidepressant properties. Although initially thought to be free of extrapyramidal side effects, sulpiride‐induced tardive dyskinesia and parkinsonism have been reported occasionally. We studied a 37‐year‐old man who developed persistent segmental dystonia within 2 months after starting sulpiride therapy. We could not find any previous reports of sulpiride‐induced tardive dystonia.
Url:
DOI: 10.1002/mds.870050119
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003B72
- to stream Istex, to step Curation: 003B72
- to stream Istex, to step Checkpoint: 004361
- to stream PubMed, to step Corpus: 004F45
- to stream PubMed, to step Curation: 004F45
- to stream PubMed, to step Checkpoint: 004E75
- to stream Ncbi, to step Merge: 002784
- to stream Ncbi, to step Curation: 002784
- to stream Ncbi, to step Checkpoint: 002784
- to stream Main, to step Merge: 009606
- to stream PascalFrancis, to step Corpus: 003988
- to stream PascalFrancis, to step Curation: 002E37
- to stream PascalFrancis, to step Checkpoint: 003921
- to stream Main, to step Merge: 009697
- to stream Main, to step Curation: 006272
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Sulpiride‐induced tardive dystonia</title><author><name sortKey="Miller, Lucinda G" sort="Miller, Lucinda G" uniqKey="Miller L" first="Lucinda G." last="Miller">Lucinda G. Miller</name></author><author><name sortKey="Jankovic" sort="Jankovic" uniqKey="Jankovic" last="Jankovic">Jankovic</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:F419D35E0DD2E2934DEA8404678245319EF21ED2</idno><date when="1990" year="1990">1990</date><idno type="doi">10.1002/mds.870050119</idno><idno type="url">https://api.istex.fr/document/F419D35E0DD2E2934DEA8404678245319EF21ED2/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003B72</idno><idno type="wicri:Area/Istex/Curation">003B72</idno><idno type="wicri:Area/Istex/Checkpoint">004361</idno><idno type="wicri:doubleKey">0885-3185:1990:Miller L:sulpiride:induced:tardive</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:1967484</idno><idno type="wicri:Area/PubMed/Corpus">004F45</idno><idno type="wicri:Area/PubMed/Curation">004F45</idno><idno type="wicri:Area/PubMed/Checkpoint">004E75</idno><idno type="wicri:Area/Ncbi/Merge">002784</idno><idno type="wicri:Area/Ncbi/Curation">002784</idno><idno type="wicri:Area/Ncbi/Checkpoint">002784</idno><idno type="wicri:doubleKey">0885-3185:1990:Miller L:sulpiride:induced:tardive</idno><idno type="wicri:Area/Main/Merge">009606</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:90-0168298</idno><idno type="wicri:Area/PascalFrancis/Corpus">003988</idno><idno type="wicri:Area/PascalFrancis/Curation">002E37</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">003921</idno><idno type="wicri:doubleKey">0885-3185:1990:Miller L:sulpiride:induced:tardive</idno><idno type="wicri:Area/Main/Merge">009697</idno><idno type="wicri:Area/Main/Curation">006272</idno><idno type="wicri:Area/Main/Exploration">006272</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Sulpiride‐induced tardive dystonia</title><author><name sortKey="Miller, Lucinda G" sort="Miller, Lucinda G" uniqKey="Miller L" first="Lucinda G." last="Miller">Lucinda G. Miller</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Family Medicine, Baylor College of Medicine, Houston, Texas</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Jankovic" sort="Jankovic" uniqKey="Jankovic" last="Jankovic">Jankovic</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Baylor College of Medicine, Houston, Texas</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1990">1990</date><biblScope unit="vol">5</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="83">83</biblScope><biblScope unit="page" to="84">84</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">F419D35E0DD2E2934DEA8404678245319EF21ED2</idno><idno type="DOI">10.1002/mds.870050119</idno><idno type="ArticleID">MDS870050119</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Antidepressant agent</term><term>Antipsychotic Agents (adverse effects)</term><term>Antipsychotic Agents (therapeutic use)</term><term>Case study</term><term>D2 Dopamine receptor</term><term>Dopamine antagonist</term><term>Dyskinesia, Drug-Induced (etiology)</term><term>Dystonia</term><term>Dystonia (chemically induced)</term><term>Human</term><term>Humans</term><term>Late</term><term>Male</term><term>Nervous system diseases</term><term>Parkinsonism</term><term>Psychotic Disorders (drug therapy)</term><term>Psychotropic</term><term>Receptors, Dopamine (drug effects)</term><term>Receptors, Dopamine D2</term><term>Sulpiride</term><term>Sulpiride (adverse effects)</term><term>Sulpiride (therapeutic use)</term><term>Tardive dystonia</term><term>Toxicity</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antipsychotic Agents</term><term>Sulpiride</term></keywords><keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en"><term>Receptors, Dopamine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antipsychotic Agents</term><term>Sulpiride</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Dystonia</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Psychotic Disorders</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dyskinesia, Drug-Induced</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Humans</term><term>Male</term><term>Receptors, Dopamine D2</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Antagoniste dopamine</term><term>Antidépresseur</term><term>Dystonie</term><term>Etude cas</term><term>Homme</term><term>Psychotrope</term><term>Récepteur dopaminergique D2</term><term>Sulpiride</term><term>Système nerveux pathologie</term><term>Tardif</term><term>Toxicité</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Sulpiride is a selective D2‐receptor antagonist with antipsychotic and antidepressant properties. Although initially thought to be free of extrapyramidal side effects, sulpiride‐induced tardive dyskinesia and parkinsonism have been reported occasionally. We studied a 37‐year‐old man who developed persistent segmental dystonia within 2 months after starting sulpiride therapy. We could not find any previous reports of sulpiride‐induced tardive dystonia.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Texas</li></region></list><tree><country name="États-Unis"><region name="Texas"><name sortKey="Miller, Lucinda G" sort="Miller, Lucinda G" uniqKey="Miller L" first="Lucinda G." last="Miller">Lucinda G. Miller</name></region><name sortKey="Jankovic" sort="Jankovic" uniqKey="Jankovic" last="Jankovic">Jankovic</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006272 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006272 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:F419D35E0DD2E2934DEA8404678245319EF21ED2
|texte= Sulpiride‐induced tardive dystonia
}}
| This area was generated with Dilib version V0.6.23. |  |